Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    DENTSPLY SIRONA Inc. (XRAY)

    Price:

    13.19 USD

    ( + 0.23 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    XRAY
    Name
    DENTSPLY SIRONA Inc.
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    Price
    13.190
    Market Cap
    2.631B
    Enterprise value
    5.857B
    Currency
    USD
    Ceo
    Simon D. Campion
    Full Time Employees
    14000
    Ipo Date
    1987-08-12
    City
    Charlotte
    Address
    13320 Ballantyne Corporate Place

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Merit Medical Systems, Inc.

    VALUE SCORE:

    8

    Symbol
    MMSI
    Market Cap
    4.987B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    2nd position

    LeMaitre Vascular, Inc.

    VALUE SCORE:

    9

    Symbol
    LMAT
    Market Cap
    1.989B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    The best

    Pro-Dex, Inc.

    VALUE SCORE:

    10

    Symbol
    PDEX
    Market Cap
    110.989M
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -2.770
    P/S
    0.717
    P/B
    1.341
    Debt/Equity
    1.272
    EV/FCF
    34.538
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    1.298
    Earnings yield
    -0.361
    Debt/assets
    0.411
    FUNDAMENTALS
    Net debt/ebidta
    -3.085
    Interest coverage
    -10.770
    Research And Developement To Revenue
    0.042
    Intangile to total assets
    0.438
    Capex to operating cash flow
    0.512
    Capex to revenue
    0.039
    Capex to depreciation
    0.422
    Return on tangible assets
    -0.278
    Debt to market cap
    0.948
    Piotroski Score
    6.000
    FUNDAMENTALS
    PEG
    0.599
    P/CF
    9.289
    P/FCF
    19.067
    RoA %
    -15.637
    RoIC %
    -13.381
    Gross Profit Margin %
    51.675
    Quick Ratio
    1.107
    Current Ratio
    1.686
    Net Profit Margin %
    -25.851
    Net-Net
    -14.686
    FUNDAMENTALS PER SHARE
    FCF per share
    0.692
    Revenue per share
    18.419
    Net income per share
    -4.762
    Operating cash flow per share
    1.420
    Free cash flow per share
    0.692
    Cash per share
    1.801
    Book value per share
    9.839
    Tangible book value per share
    -3.512
    Shareholders equity per share
    9.834
    Interest debt per share
    12.885
    TECHNICAL
    52 weeks high
    25.220
    52 weeks low
    12.140
    Current trading session High
    13.320
    Current trading session Low
    12.980
    DIVIDEND
    Dividend yield
    4.85%
    Payout ratio
    -13.5%
    Years of div. Increase
    14.000
    Years of div.
    32.000
    Q-shift
    1.000
    Dividend per share
    0.640
    SIMILAR COMPANIES
    logo

    Country
    CH
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.004308607%
    Payout Ratio
    15.707953%
    P/E
    35.712
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -14.931
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.021486493%
    Payout Ratio
    73.10087%
    P/E
    34.719
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    34.660
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    14.872
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    27.469
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -81.421
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    41.808
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.007861014%
    Payout Ratio
    22.194253%
    P/E
    29.132
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.01038961%
    Payout Ratio
    32.1685%
    P/E
    31.224
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.0030818903%
    Payout Ratio
    12.323149%
    P/E
    40.406
    DESCRIPTION

    DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.

    NEWS
    https://images.financialmodelingprep.com/news/dentsply-sirona-appoints-aldo-m-denti-as-chief-commercial-20251002.jpg
    Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization

    globenewswire.com

    2025-10-02 08:30:00

    CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer (CCO), effective October 6, 2025. The appointment is designed to sharpen the Company's focus on the customer by aligning its Global Business Units and Commercial Organizations more closely - streamlining how Dentsply Sirona works and delivers.

    https://images.financialmodelingprep.com/news/dentsply-sirona-and-pearl-partner-to-deliver-advanced-aiassisted-20250925.jpg
    Dentsply Sirona and Pearl Partner to Deliver Advanced AI-Assisted Radiologic Support via DS Core Integration

    businesswire.com

    2025-09-25 10:56:00

    LOS ANGELES--(BUSINESS WIRE)-- #ArtificialIntelligence--Dentsply Sirona adds Pearl's Second Opinion dental AI capabilities to its cloud-based DS Core imaging software.

    https://images.financialmodelingprep.com/news/dentsply-sirona-retains-wellspect-following-strategic-review-20250910.jpg
    Dentsply Sirona Retains Wellspect Following Strategic Review

    zacks.com

    2025-09-10 10:05:41

    XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.

    https://images.financialmodelingprep.com/news/dentsply-sirona-inc-xray-presents-at-baird-2025-global-20250909.jpg
    DENTSPLY SIRONA Inc. (XRAY) Presents At Baird 2025 Global Healthcare Conference (Transcript)

    seekingalpha.com

    2025-09-09 17:06:58

    DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Baird 2025 Global Healthcare Conference September 9, 2025 1:25 PM EDT Company Participants Matthew Garth - Executive VP & CFO Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Presentation Jeffrey Johnson Senior Research Analyst All right.

    https://images.financialmodelingprep.com/news/dentsply-sirona-inc-xray-presents-at-morgan-stanley-23rd-20250908.jpg
    DENTSPLY SIRONA Inc. (XRAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

    seekingalpha.com

    2025-09-08 19:58:14

    DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT Company Participants Daniel Scavilla - President, CEO & Director Matthew Garth - Executive VP & CFO Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good afternoon, everyone. My name is Erin Wright, the health care services analyst at Morgan Stanley.

    https://images.financialmodelingprep.com/news/dentsply-sirona-retains-wellspect-healthcare-as-a-portfolio-business-20250908.jpg
    Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives

    globenewswire.com

    2025-09-08 08:30:00

    Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company

    https://images.financialmodelingprep.com/news/dentsply-sirona-to-participate-in-upcoming-investor-conferences-20250826.jpeg
    Dentsply Sirona to Participate in Upcoming Investor Conferences

    globenewswire.com

    2025-08-26 16:30:00

    CHARLOTTE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.

    https://images.financialmodelingprep.com/news/is-the-options-market-predicting-a-spike-in-dentsply-20250821.jpg
    Is the Options Market Predicting a Spike in DENTSPLY Stock?

    zacks.com

    2025-08-21 10:45:40

    Investors need to pay close attention to XRAY stock based on the movements in the options market lately.

    https://images.financialmodelingprep.com/news/dentsply-sirona-turnaround-potential-and-digital-workflows-20250819.jpg
    Dentsply Sirona: Turnaround Potential And Digital Workflows

    seekingalpha.com

    2025-08-19 09:11:53

    XRAY's EDS and Wellspect are the key to stabilizing their results going forward. OIS and CTS continue to decline, but SureSmile grows in Europe. Their new CEO will also prioritize execution, rather than reinventing XRAY. They'll double down on integrated digital workflows and better customer experience. If they build a stickier ecosystem, I think XRAY does have the potential for a turnaround.

    https://images.financialmodelingprep.com/news/international-markets-and-dentsply-xray-a-deep-dive-for-20250811.jpg
    International Markets and Dentsply (XRAY): A Deep Dive for Investors

    zacks.com

    2025-08-11 10:15:38

    Explore Dentsply's (XRAY) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

    https://images.financialmodelingprep.com/news/why-dentsply-international-xray-is-a-top-growth-stock-20250808.jpg
    Why Dentsply International (XRAY) is a Top Growth Stock for the Long-Term

    zacks.com

    2025-08-08 10:46:05

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

    https://images.financialmodelingprep.com/news/dentsply-sirona-inc-xray-q2-2025-earnings-call-transcript-20250808.jpg
    DENTSPLY SIRONA Inc. (XRAY) Q2 2025 Earnings Call Transcript

    seekingalpha.com

    2025-08-08 09:15:33

    DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Daniel T. Scavilla - President, CEO & Director Matthew E.

    https://images.financialmodelingprep.com/news/xray-stock-rises-on-q2-earnings-revenues-beat-adjusted-20250807.jpg
    XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up

    zacks.com

    2025-08-07 12:11:06

    DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.

    https://images.financialmodelingprep.com/news/dentsply-xray-q2-earnings-how-key-metrics-compare-to-20250807.jpg
    Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

    zacks.com

    2025-08-07 10:32:18

    The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

    https://images.financialmodelingprep.com/news/dentsply-international-xray-tops-q2-earnings-and-revenue-estimates-20250807.jpg
    Dentsply International (XRAY) Tops Q2 Earnings and Revenue Estimates

    zacks.com

    2025-08-07 08:16:07

    Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.49 per share a year ago.

    https://images.financialmodelingprep.com/news/dentsply-sirona-reports-second-quarter-2025-results-20250807.jpg
    Dentsply Sirona Reports Second Quarter 2025 Results

    globenewswire.com

    2025-08-07 06:00:00

    CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2025.